Clinical and Radiological effects of Dienogest on Patients with symptomatic uterine myoma vs Levonorgestrel IUD .

Clinical and Radiological effects of Dienogest on Patients with symptomatic uterine myoma vs Levonorgestrel IUD .A Randomized control trial.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202506543835976

Enrollment

Registered

2025-06-27

Start date

2025-07-15

Completion date

Unknown

Last updated

2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fibroid

Interventions

Deinogest group

Mirena

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1- Women age 20-50 years. 2- Syroidbmptomatic bleeding with uterine fi

Exclusion criteria

Exclusion criteria: 1- women seeking hysterectomy or myomectomy 2- women refusing participation in the study

Design outcomes

Primary

Measure	Time frame
Uterine myoma size as measured by ultrasound	—

Secondary

Measure	Time frame
uterine bleeding as measured by pectorial blood chart	—

Countries

Egypt

Contacts

Public Contactahmed sherif

professor

ahmedgyna@yahoo.com00201227960980

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Feb 4, 2026